Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.48 USD | +0.47% | +0.14% | +123.52% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Wedbush Downgrades Fusion Pharmaceuticals to Neutral From Outperform on Heels of Announced Sale to AstraZeneca, Adjusts PT to $24 From $13